forty-four evaluable patients with breast carcinoma previously treated with combination chemotherapy consisting of cyclophosphamide , methotrexate , and 5-fluorouracil ( cmf ) were treated with a combination chemotherapy regimen consisting of doxorubicin ( a ) ( 20 mg/m2 on days 1 , 8 , 15 , and 22 , repeated every 28 days ) and mitomycin ( mit ) ( 10 mg/m2 on day 1 , repeated every 28 days ) .
C0025677
methotrexate
C0950521
cmf